Lignocaine HCl 2 % + Adrenaline Tartr. 0,0036 % Kela 20 mg/ml - 0.036 mg/ml Oplossing voor injectie
Lignocaine HCl 2 % + Adrenaline Tartr. 0,0036 % Kela 20 mg/ml - 0.036 mg/ml Oplossing voor injectie
Authorised
- Lidocaine hydrochloride
- EPINEPHRINE BITARTRATE
Product identification
Medicine name:
Lignocaine HCl 2 % + Adrenaline Tartr. 0,0036 % Kela 20 mg/ml - 0.036 mg/ml Oplossing voor injectie
Lignocaine HCl 2 % + Adrenaline Tartr. 0,0036 % Kela 20 mg/ml - 0.036 mg/ml Injektionslösung
Lignocaine HCl 2 % + Adrenaline Tartr. 0,0036 % Kela 20 mg/ml - 0.036 mg/ml Solution injectable
Active substance:
- Lidocaine hydrochloride
- EPINEPHRINE BITARTRATE
Target species:
-
Cat
-
Horse
-
Dog
Route of administration:
-
Epidural use
-
Intramuscular use
-
Subcutaneous use
Product details
Active substance and strength:
-
Lidocaine hydrochloride20.00/milligram(s)1.00millilitre(s)
-
EPINEPHRINE BITARTRATE0.04/milligram(s)1.00millilitre(s)
Pharmaceutical form:
-
Solution for injection
Withdrawal period by route of administration:
-
Epidural use
-
Cat
-
Horse
-
Meat and offal3day
-
-
Dog
-
-
Intramuscular use
-
Cat
-
Dog
-
Horse
-
Meat and offal3day
-
-
-
Subcutaneous use
-
Dog
-
Cat
-
Horse
-
Meat and offal3day
-
-
Anatomical therapeutic chemical veterinary (ATCvet) codes:
- QN01BB52
Legal status of supply:
-
Veterinary medicinal product subject to veterinary prescription
Authorisation status:
-
Valid
Authorised in:
-
Belgium
Package description:
- Lignocaine HCl 2 % + Adrenaline Tartr. 0,0036 % Kela 20 mg/ml - 0.036 mg/ml Solution for injection Vial of 250 ml
- Lignocaine HCl 2 % + Adrenaline Tartr. 0,0036 % Kela 20 mg/ml - 0.036 mg/ml Solution for injection Vial of 100 ml
- Lignocaine HCl 2 % + Adrenaline Tartr. 0,0036 % Kela 20 mg/ml - 0.036 mg/ml Solution for injection Vial of 50 ml
- Lignocaine HCl 2 % + Adrenaline Tartr. 0,0036 % Kela 20 mg/ml - 0.036 mg/ml Solution for injection Vial of 30 ml
- Lignocaine HCl 2 % + Adrenaline Tartr. 0,0036 % Kela 20 mg/ml - 0.036 mg/ml Solution for injection 12 Vials of 30 ml
- Lignocaine HCl 2 % + Adrenaline Tartr. 0,0036 % Kela 20 mg/ml - 0.036 mg/ml Solution for injection 12 Vials of 50 ml
- Lignocaine HCl 2 % + Adrenaline Tartr. 0,0036 % Kela 20 mg/ml - 0.036 mg/ml Solution for injection 12 Vials of 100 ml
- Lignocaine HCl 2 % + Adrenaline Tartr. 0,0036 % Kela 20 mg/ml - 0.036 mg/ml Solution for injection 12 Vials of 250 ml
Additional information
Entitlement type:
-
Marketing Authorisation
Legal basis of product authorisation:
-
Full application (Article 12(3) of Directive No 2001/82/EC)
Marketing authorisation holder:
- Kela Kempisch Laboratorium Kela Laboratoria
Marketing authorisation date:
Manufacturing sites for batch release:
- KELA Kempisch Laboratorium Kela Laboratoria
Responsible authority:
- Federal Agency For Medicines And Health Products
Authorisation number:
- BE-V112734
Date of authorisation status change:
To consult adverse reactions on veterinary medicinal products please go to www.adrreports.eu/vet
Documents
Package Leaflet
This document does not exist in this language (English). You can find it
in another language below.
Summary of Product Characteristics
This document does not exist in this language (English). You can find it
in another language below.
Labelling
This document does not exist in this language (English). You can find it
in another language below.
How useful was this page?:
